Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd...

FDA Recall #D-0001-2026 — Class II — September 24, 2025

Recall #D-0001-2026 Date: September 24, 2025 Classification: Class II Status: Ongoing

Product Description

Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Reason for Recall

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Recalling Firm

Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

912 30-count bottles

Distribution

Distributed Nationwide in the USA

Code Information

Lot#: E409308, Exp 12/31/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated